Geode Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30M Buy
2,667,642
+80,155
+3% +$903K ﹤0.01% 1731
2025
Q1
$24.5M Buy
2,587,487
+73,594
+3% +$697K ﹤0.01% 1793
2024
Q4
$28.3M Sell
2,513,893
-6,925
-0.3% -$77.9K ﹤0.01% 1771
2024
Q3
$71.3M Sell
2,520,818
-80,757
-3% -$2.28M 0.01% 1221
2024
Q2
$49.8M Buy
2,601,575
+131,713
+5% +$2.52M ﹤0.01% 1364
2024
Q1
$81M Buy
2,469,862
+104,446
+4% +$3.43M 0.01% 1064
2023
Q4
$78.1M Buy
2,365,416
+147,967
+7% +$4.89M 0.01% 1022
2023
Q3
$60.4M Buy
2,217,449
+241,337
+12% +$6.57M 0.01% 1105
2023
Q2
$59.9M Buy
1,976,112
+352,722
+22% +$10.7M 0.01% 1117
2023
Q1
$52.7M Buy
1,623,390
+62,313
+4% +$2.02M 0.01% 1145
2022
Q4
$43.8M Buy
1,561,077
+134,352
+9% +$3.77M 0.01% 1239
2022
Q3
$51.3M Buy
1,426,725
+35,036
+3% +$1.26M 0.01% 1067
2022
Q2
$42.7M Sell
1,391,689
-11,896
-0.8% -$365K 0.01% 1234
2022
Q1
$45.3M Buy
1,403,585
+68,707
+5% +$2.22M 0.01% 1319
2021
Q4
$36.9M Buy
1,334,878
+18,308
+1% +$507K ﹤0.01% 1531
2021
Q3
$40.8M Buy
1,316,570
+20,837
+2% +$646K 0.01% 1440
2021
Q2
$27.4M Buy
1,295,733
+67,520
+5% +$1.43M ﹤0.01% 1760
2021
Q1
$24.8M Buy
1,228,213
+104,735
+9% +$2.12M ﹤0.01% 1738
2020
Q4
$18M Buy
1,123,478
+57,756
+5% +$926K ﹤0.01% 1786
2020
Q3
$13.2M Sell
1,065,722
-39,787
-4% -$494K ﹤0.01% 1790
2020
Q2
$7.87M Buy
1,105,509
+45,187
+4% +$322K ﹤0.01% 2076
2020
Q1
$5.76M Buy
1,060,322
+88,468
+9% +$480K ﹤0.01% 2059
2019
Q4
$8.8M Buy
971,854
+39,313
+4% +$356K ﹤0.01% 2099
2019
Q3
$6.7M Buy
932,541
+47,761
+5% +$343K ﹤0.01% 2208
2019
Q2
$7.03M Buy
884,780
+103,979
+13% +$827K ﹤0.01% 2170
2019
Q1
$9.82M Buy
780,801
+41,741
+6% +$525K ﹤0.01% 1903
2018
Q4
$14.7M Buy
739,060
+70,363
+11% +$1.4M ﹤0.01% 1493
2018
Q3
$19M Buy
668,697
+60,092
+10% +$1.71M 0.01% 1447
2018
Q2
$12.8M Buy
608,605
+95,849
+19% +$2.02M ﹤0.01% 1684
2018
Q1
$7.31M Buy
512,756
+9,341
+2% +$133K ﹤0.01% 1995
2017
Q4
$6.19M Buy
503,415
+18,461
+4% +$227K ﹤0.01% 2088
2017
Q3
$8.63M Buy
484,954
+171,430
+55% +$3.05M ﹤0.01% 1832
2017
Q2
$7.95M Buy
313,524
+183,471
+141% +$4.65M ﹤0.01% 1820
2017
Q1
$2.9M Buy
130,053
+3,889
+3% +$86.7K ﹤0.01% 2434
2016
Q4
$1.87M Buy
126,164
+9,352
+8% +$138K ﹤0.01% 2667
2016
Q3
$2.88M Buy
116,812
+27,622
+31% +$680K ﹤0.01% 2322
2016
Q2
$1.71M Buy
89,190
+14,105
+19% +$271K ﹤0.01% 2574
2016
Q1
$792 Buy
75,085
+948
+1% +$10 ﹤0.01% 3006
2015
Q4
$897K Buy
74,137
+23,732
+47% +$287K ﹤0.01% 2966
2015
Q3
$804K Buy
+50,405
New +$804K ﹤0.01% 2991